1-9 of 9
Lana A. Vornik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ

Anne E. O'Shea, Guy T. Clifton, Na Qiao, Brandy M. Heckman-Stoddard, Malgorzata Wojtowicz, Eileen Dimond, Isabelle Bedrosian, Diane Weber, Judy E. Garber, Alexander Husband, Ricardo Pastorello, J. Jack Lee, Mike Hernandez, Diane D. Liu, Lana A. Vornik, Powel H. Brown, Gheath Alatrash, George E. Peoples, Elizabeth A. Mittendorf
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2023) 16 (6): 333–341.
https://doi.org/10.1158/1940-6207.CAPR-22-0388
Published: 01 June 2023
View article titled, Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma <em>In Situ</em>
Open the PDF for Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma <em>In Situ</em> in another window
Includes: Supplementary data
Journal Articles

Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor

Suet-Ying Kwan, Alyssa N. Slayden, Aubrey R. Coronado, Rosamaria C. Marquez, Huiqin Chen, Peng Wei, Michelle I. Savage, Lana A. Vornik, Jennifer T. Fox, Shizuko Sei, Dong Liang, Heather L. Stevenson, Gregory K. Wilkerson, Mihai Gagea, Powel H. Brown, Laura Beretta
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2023) 16 (1): 17–28.
https://doi.org/10.1158/1940-6207.CAPR-22-0332
Published: 04 January 2023
View article titled, Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor
Open the PDF for Treatment Strategies and Mechanisms Associated with the Prevention of NASH-Associated HCC by a Toll-like Receptor 4 Inhibitor in another window
Includes: Supplementary data
Journal Articles

Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer

Parijatham S. Thomas, Anisha B. Patel, J. Jack Lee, Diane D. Liu, Mike Hernandez, Miguel Muzzio, Alejandro Contreras, Valerie Sepeda, Carrie Mays, Diane Weber, Lana A. Vornik, Seema A. Khan, Eileen Dimond, Brandy M. Heckman-Stoddard, Marjorie Perloff, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2023) 16 (1): 47–55.
https://doi.org/10.1158/1940-6207.CAPR-22-0210
Published: 04 January 2023
View article titled, Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer
Open the PDF for Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

Abhijit Mazumdar, William M. Tahaney, Jamal L. Hill, Yun Zhang, Sumankalai Ramachandran, Jitesh Kawedia, Jing Qian, Alejandro Contreras, Michelle I. Savage, Lana A. Vornik, Shizuko Sei, Altaf Mohammed, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (12): 791–802.
https://doi.org/10.1158/1940-6207.CAPR-22-0106
Published: 01 December 2022
View article titled, Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
Open the PDF for Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Meghna S. Trivedi, Nadir Arber, Eitan Friedman, Judy E. Garber, Kevin Holcomb, Neil S. Horowitz, Jason D. Wright, J. Jack Lee, Lana A. Vornik, Saba Abutaseh, Tawana Castile, Edward R. Sauter, Eileen Dimond, Brandy M. Heckman-Stoddard, Margaret House, Goli Samimi, Powel H. Brown, Katherine D. Crew
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2022) 15 (11): 721–726.
https://doi.org/10.1158/1940-6207.CAPR-22-0051
Published: 01 November 2022
View article titled, Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic <em>BRCA1/2</em> Variant Scheduling Risk-Reducing Salpingo-Oophorectomy
Open the PDF for Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic <em>BRCA1/2</em> Variant Scheduling Risk-Reducing Salpingo-Oophorectomy in another window
Journal Articles

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

Ayca Gucalp, Xi K. Zhou, Elise D. Cook, Judy E. Garber, Katherine D. Crew, Julie R. Nangia, Priya Bhardwaj, Dilip D. Giri, Olivier Elemento, Akanksha Verma, Hanhan Wang, J. Jack Lee, Lana A. Vornik, Carrie Mays, Diane Weber, Valerie Sepeda, Holly O'Kane, Margaret Krasne, Samantha Williams, Patrick G. Morris, Brandy M. Heckman-Stoddard, Barbara K. Dunn, Clifford A. Hudis, Powel H. Brown, Andrew J. Dannenberg
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2018) 11 (4): 203–214.
https://doi.org/10.1158/1940-6207.CAPR-17-0354
Published: 01 April 2018
View article titled, A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Open the PDF for A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease in another window
Includes: Supplementary data
Journal Articles

Abstract C49: A randomized phase II trial of low-dose aspirin versus placebo in high-risk individuals with CT screen-detected subsolid lung nodules

Aliana Guerrieri-Gonzaga, Giulia Veronesi, Pier Paolo Di Fiore, Matteo Lazzeroni, Massimo Bellomi, Eva Szabo, Lana A. Vornik, Powel H. Brown, Bernardo Bonanni
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C49.
https://doi.org/10.1158/1940-6215.PREV-13-C49
Published: 28 August 2014
View article titled, Abstract C49: A randomized phase II trial of low-dose aspirin versus placebo in high-risk individuals with CT screen-detected subsolid lung nodules
Journal Articles

Abstract C52: A phase Ib biomarker trial of naproxen in patients at risk for DNA mismatch repair deficient colorectal cancer

Eduardo Vilar, Y. Nancy You, Lana A. Vornik, Elena M. Stoffel, Ramona M. Lim, Steven M. Lipkin, Marjorie Perloff, Powel H. Brown
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C52.
https://doi.org/10.1158/1940-6215.PREV-13-C52
Published: 28 August 2014
View article titled, Abstract C52: A phase Ib biomarker trial of naproxen in patients at risk for DNA mismatch repair deficient colorectal cancer
Journal Articles

Abstract B17: Phase I prevention study of atorvastatin in women at increased risk for breast cancer

Banu Arun, Yun Gong, Diane Liu, Jennifer Litton, Angelica Gutierrez-Barrera, Blessy Sajan, Jack j. Lee, Lana A. Vornik, Terri Cornelison, Gabriel N. Hortobagyi, Scott Lippman, Powel H. Brown, nour Sneige
Journal: Cancer Prevention Research
Cancer Prev Res (Phila) (2012) 5 (11_Supplement): B17.
https://doi.org/10.1158/1940-6207.PREV-12-B17
Published: 23 January 2014
View article titled, Abstract B17: Phase I prevention study of atorvastatin in women at increased risk for breast cancer